Price$11.37+3.04 (+36.49%)
2026-01-292026-05-04
News · 26 weeks50+150%
2026-01-252026-07-19
Mix3490d
- Insider17(50%)
- SEC Filings12(35%)
- Other3(9%)
- Leadership2(6%)
Latest news
25 items- SECSEC Form EFFECT filed by Ekso Bionics Holdings Inc.EFFECT - ChronoScale Holdings Corp (0001549084) (Filer)
- INSIDERChief Executive Officer Chen Ying Cenly was granted 2,800,000 shares (SEC Form 4)4 - ChronoScale Holdings Corp (0001549084) (Issuer)
- SECAmendment: SEC Form S-3/A filed by Ekso Bionics Holdings Inc.S-3/A - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form S-8 filed by Ekso Bionics Holdings Inc.S-8 - ChronoScale Holdings Corp (0001549084) (Filer)
- SECSEC Form 8-K12B filed by Ekso Bionics Holdings Inc.8-K12B - ChronoScale Corp (0001549084) (Filer)
- SECSEC Form S-3 filed by Ekso Bionics Holdings Inc.S-3 - ChronoScale Corp (0001549084) (Filer)
- INSIDERDirector Schaap Andrew Cordell was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by new insider Schaap Andrew Cordell3 - ChronoScale Corp (0001549084) (Issuer)
- SECAmendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Other Events8-K/A - ChronoScale Corp (0001549084) (Filer)
- SECEkso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - ChronoScale Corp (0001549084) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Ekso Bionics Holdings Inc.SCHEDULE 13D/A - ChronoScale Corp (0001549084) (Subject)
- SECEkso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - ChronoScale Corp (0001549084) (Filer)
- SECEkso Bionics Holdings Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities8-K - ChronoScale Corp (0001549084) (Filer)
- PRChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure StrategyDALLAS, June 04, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ:CHRN) ("ChronoScale" or the "Company"), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointments of Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer. The appointments strengthen ChronoScale's executive leadership team as the Company expands its AI infrastructure platform and accelerates delivery of large-scale compute solutions for enterprises, hyperscalers, and AI innovators worldwide. "AI infrastructure is entering a new era where performance, efficiency, and execution matter more than ever," said Ce
- SECAmendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - ChronoScale Corp (0001549084) (Filer)
- INSIDERDirector Cummins Wes was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Miller Douglas S was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Benson Ella G. was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Nottenburg Richard N was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERChief Financial Officer Wong Jerome was granted 40,000 shares, increasing direct ownership by 161% to 64,771 units (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Davis Scott G. was granted 109,357 shares, increasing direct ownership by 139% to 188,134 units (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Clancy William M was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by Ekso Bionics Holdings Inc.3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by Ekso Bionics Holdings Inc.3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Ying Cenly3 - ChronoScale Corp (0001549084) (Issuer)
EKSO FAQ
5 questionsWhat does Ekso Bionics Holdings Inc. do?
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock...Where does EKSO stock trade?
Ekso Bionics Holdings Inc. (EKSO) is listed on NASDAQ.What sector and industry is EKSO in?
Ekso Bionics Holdings Inc. operates in the Industrials sector, Industrial Machinery/Components industry.What companies are similar to EKSO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare EKSO side-by-side with any of them on Quantisnow.How can I track EKSO on Quantisnow?
Quantisnow aggregates Ekso Bionics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EKSO to receive live email and push alerts on every new disclosure.